PMID: 32156863Mar 12, 2020Paper

A Case of Nephrotic Syndrome Induced by FOLFIRI plus Ramucirumab for Metastatic Descending Colon Cancer

Gan to kagaku ryoho. Cancer & chemotherapy
Tatsushi ShingaiHiroaki Ohigashi

Abstract

We report a case of multiple lung metastases of RAS mutant type descending colon cancer with development of nephrotic syndrome after the introduction of FOLFIRI plus ramucirumab(RAM). A female patient in her 50s underwent adjuvant chemotherapy with capecitabine and oxaliplatin after primary tumor and partial lung resection. For recurrent multiple lung metastases, 4 years of capecitabine and bevacizumab therapy was administered. FOLFIRI plus RAM therapy was introduced because of tumor progression. After treatment, the patient showed increased urine protein content, decreased serum albumin levels, marked hypertension, and increased edema, and was diagnosed with nephrotic syndrome. The patient's condition improved with prednisolone, additional doses of antihypertensive, and diuretics. Even in cases where it is possible to control proteinuria during bevacizumab administration, it is necessary to keep in mind that RAM administration as second-line therapy may cause nephrotic syndrome.

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Gan to kagaku ryoho. Cancer & chemotherapy
Ryutaro SakabeYoshiyuki Maeda
La Riforma medica
R PACHIOLIL CAMPANACCI
Deutsche medizinische Wochenschrift
H Nieth
Revista clínica española
R PASCUAL SANTISO
Il Policlinico. Sezione pratica
V Cagli
© 2021 Meta ULC. All rights reserved